13 employees
Myra Vision is the first-of-its-kind treatment that allows maximum IOP reduction for patients with moderate to severe glaucoma.
2016
$25M
from 3 investors over 3 rounds
Myra Vision raised $25M on June 26, 2023
Investors: Shifamed and The Capital Partnership
Myra Vision raised $17M on June 1, 2021
Investors: The Capital Partnership